Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Ionis Pharmaceuticals, Inc.”

202 pharma patents match "Ionis Pharmaceuticals, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 202
Index total 30,257
Page 9 / 9

Quick answer

This filtered view shows 202 pharmaceutical patents matching "Ionis Pharmaceuticals, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

202 results for “Ionis Pharmaceuticals, Inc.” · 30,257 patents in full index Clear search

  1. US 9404113

    Antisense modulation of PTP1B expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  2. US 9404114

    Antisense modulation of GCGR expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted
  3. US 9399774

    Modulation of transthyretin expression

    Ionis Pharmaceuticals, Inc. · Granted Jul 26, 2016 · Expires Jul 21, 2036

    granted
  4. US 9365848

    Modulation of apolipoprotein C-III expression

    Ionis Pharmaceuticals, Inc. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted
  5. US 9353372

    Compositions and their uses directed to huntingtin

    Ionis Pharmaceuticals, Inc. · Granted May 31, 2016 · Expires May 26, 2036

    granted
  6. US 9340784

    Methods and compositions for modulating alpha-1-antitrypsin expression

    Ionis Pharmaceuticals, Inc. · Granted May 17, 2016 · Expires May 12, 2036

    granted
  7. US 9322021

    Methods for modulating kallikrein (KLKB1) expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  8. US 9321799

    Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom

    Ionis Pharmaceuticals, Inc. · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted
  9. US 9315811

    Methods for modulating kallikrein (KLKB1) expression

    Ionis Pharmaceuticals, Inc. · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted
  10. US 9273315

    Modulation of huntingtin expression

    Ionis Pharmaceuticals, Inc. · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted